The global market for Sustained Release Drug Delivery Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Sustained Release Drug Delivery System (SRDDS) is designed to release a drug at a predetermined rate by maintaining a constant drug level for a specific period of time with minimum side effects.

North American market for Sustained Release Drug Delivery Systems is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Sustained Release Drug Delivery Systems is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Sustained Release Drug Delivery Systems include West Pharmaceutical Services, Cirtec Medical, Balda, Lubrizol, Beckman Coulter, Scios, Noven Pharmaceuticals, Raritan Pharmaceuticals, Parker Hannifin, Nitto Avecia Pharma Services, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sustained Release Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sustained Release Drug Delivery Systems.

The Sustained Release Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sustained Release Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sustained Release Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sustained Release Drug Delivery Systems Market Report

Report Metric	Details
Report Name	Sustained Release Drug Delivery Systems Market
Segment by Type	Nonbiodegradable Implants Biodegradable Implants Micro- and Nano-Particles Liposomes ECT
Segment by Application	Hospitals Clinics Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	West Pharmaceutical Services, Cirtec Medical, Balda, Lubrizol, Beckman Coulter, Scios, Noven Pharmaceuticals, Raritan Pharmaceuticals, Parker Hannifin, Nitto Avecia Pharma Services, KV Pharmaceutical, Equashield, Shire Laboratories, Powder Systems, B. Braun OEM Division, Pharmaco-Kinesis, Foresee, Bayer, Catalent, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sustained Release Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sustained Release Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sustained Release Drug Delivery Systems Market report?

Ans: The main players in the Sustained Release Drug Delivery Systems Market are West Pharmaceutical Services, Cirtec Medical, Balda, Lubrizol, Beckman Coulter, Scios, Noven Pharmaceuticals, Raritan Pharmaceuticals, Parker Hannifin, Nitto Avecia Pharma Services, KV Pharmaceutical, Equashield, Shire Laboratories, Powder Systems, B. Braun OEM Division, Pharmaco-Kinesis, Foresee, Bayer, Catalent, Pfizer

What are the Application segmentation covered in the Sustained Release Drug Delivery Systems Market report?

Ans: The Applications covered in the Sustained Release Drug Delivery Systems Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Sustained Release Drug Delivery Systems Market report?

Ans: The Types covered in the Sustained Release Drug Delivery Systems Market report are Nonbiodegradable Implants, Biodegradable Implants, Micro- and Nano-Particles, Liposomes, ECT

1 Sustained Release Drug Delivery Systems Market Overview

1.1 Product Definition

1.2 Sustained Release Drug Delivery Systems by Type

1.2.1 Global Sustained Release Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031)

1.2.2 Nonbiodegradable Implants

1.2.3 Biodegradable Implants

1.2.4 Micro- and Nano-Particles

1.2.5 Liposomes

1.2.6 ECT

1.3 Sustained Release Drug Delivery Systems by Application

1.3.1 Global Sustained Release Drug Delivery Systems Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Sustained Release Drug Delivery Systems Market Size Estimates and Forecasts

1.4.1 Global Sustained Release Drug Delivery Systems Revenue 2020-2031

1.4.2 Global Sustained Release Drug Delivery Systems Sales 2020-2031

1.4.3 Global Sustained Release Drug Delivery Systems Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Sustained Release Drug Delivery Systems Market Competition by Manufacturers

2.1 Global Sustained Release Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)

2.2 Global Sustained Release Drug Delivery Systems Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Sustained Release Drug Delivery Systems Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Sustained Release Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Sustained Release Drug Delivery Systems, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Sustained Release Drug Delivery Systems, Product Type & Application

2.7 Global Key Manufacturers of Sustained Release Drug Delivery Systems, Date of Enter into This Industry

2.8 Global Sustained Release Drug Delivery Systems Market Competitive Situation and Trends

2.8.1 Global Sustained Release Drug Delivery Systems Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Sustained Release Drug Delivery Systems Players Market Share by Revenue

2.8.3 Global Sustained Release Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Sustained Release Drug Delivery Systems Market Scenario by Region

3.1 Global Sustained Release Drug Delivery Systems Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Sustained Release Drug Delivery Systems Sales by Region: 2020-2031

3.2.1 Global Sustained Release Drug Delivery Systems Sales by Region: 2020-2025

3.2.2 Global Sustained Release Drug Delivery Systems Sales by Region: 2026-2031

3.3 Global Sustained Release Drug Delivery Systems Revenue by Region: 2020-2031

3.3.1 Global Sustained Release Drug Delivery Systems Revenue by Region: 2020-2025

3.3.2 Global Sustained Release Drug Delivery Systems Revenue by Region: 2026-2031

3.4 North America Sustained Release Drug Delivery Systems Market Facts & Figures by Country

3.4.1 North America Sustained Release Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Sustained Release Drug Delivery Systems Sales by Country (2020-2031)

3.4.3 North America Sustained Release Drug Delivery Systems Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Sustained Release Drug Delivery Systems Market Facts & Figures by Country

3.5.1 Europe Sustained Release Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Sustained Release Drug Delivery Systems Sales by Country (2020-2031)

3.5.3 Europe Sustained Release Drug Delivery Systems Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Sustained Release Drug Delivery Systems Market Facts & Figures by Region

3.6.1 Asia Pacific Sustained Release Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Sustained Release Drug Delivery Systems Sales by Region (2020-2031)

3.6.3 Asia Pacific Sustained Release Drug Delivery Systems Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Sustained Release Drug Delivery Systems Market Facts & Figures by Country

3.7.1 Latin America Sustained Release Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Sustained Release Drug Delivery Systems Sales by Country (2020-2031)

3.7.3 Latin America Sustained Release Drug Delivery Systems Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Sustained Release Drug Delivery Systems Market Facts & Figures by Country

3.8.1 Middle East and Africa Sustained Release Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Sustained Release Drug Delivery Systems Sales by Country (2020-2031)

3.8.3 Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Sustained Release Drug Delivery Systems Sales by Type (2020-2031)

4.1.1 Global Sustained Release Drug Delivery Systems Sales by Type (2020-2025)

4.1.2 Global Sustained Release Drug Delivery Systems Sales by Type (2026-2031)

4.1.3 Global Sustained Release Drug Delivery Systems Sales Market Share by Type (2020-2031)

4.2 Global Sustained Release Drug Delivery Systems Revenue by Type (2020-2031)

4.2.1 Global Sustained Release Drug Delivery Systems Revenue by Type (2020-2025)

4.2.2 Global Sustained Release Drug Delivery Systems Revenue by Type (2026-2031)

4.2.3 Global Sustained Release Drug Delivery Systems Revenue Market Share by Type (2020-2031)

4.3 Global Sustained Release Drug Delivery Systems Price by Type (2020-2031)

5 Segment by Application

5.1 Global Sustained Release Drug Delivery Systems Sales by Application (2020-2031)

5.1.1 Global Sustained Release Drug Delivery Systems Sales by Application (2020-2025)

5.1.2 Global Sustained Release Drug Delivery Systems Sales by Application (2026-2031)

5.1.3 Global Sustained Release Drug Delivery Systems Sales Market Share by Application (2020-2031)

5.2 Global Sustained Release Drug Delivery Systems Revenue by Application (2020-2031)

5.2.1 Global Sustained Release Drug Delivery Systems Revenue by Application (2020-2025)

5.2.2 Global Sustained Release Drug Delivery Systems Revenue by Application (2026-2031)

5.2.3 Global Sustained Release Drug Delivery Systems Revenue Market Share by Application (2020-2031)

5.3 Global Sustained Release Drug Delivery Systems Price by Application (2020-2031)

6 Key Companies Profiled

6.1 West Pharmaceutical Services

6.1.1 West Pharmaceutical Services Company Information

6.1.2 West Pharmaceutical Services Description and Business Overview

6.1.3 West Pharmaceutical Services Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.1.4 West Pharmaceutical Services Sustained Release Drug Delivery Systems Product Portfolio

6.1.5 West Pharmaceutical Services Recent Developments/Updates

6.2 Cirtec Medical

6.2.1 Cirtec Medical Company Information

6.2.2 Cirtec Medical Description and Business Overview

6.2.3 Cirtec Medical Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Cirtec Medical Sustained Release Drug Delivery Systems Product Portfolio

6.2.5 Cirtec Medical Recent Developments/Updates

6.3 Balda

6.3.1 Balda Company Information

6.3.2 Balda Description and Business Overview

6.3.3 Balda Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Balda Sustained Release Drug Delivery Systems Product Portfolio

6.3.5 Balda Recent Developments/Updates

6.4 Lubrizol

6.4.1 Lubrizol Company Information

6.4.2 Lubrizol Description and Business Overview

6.4.3 Lubrizol Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Lubrizol Sustained Release Drug Delivery Systems Product Portfolio

6.4.5 Lubrizol Recent Developments/Updates

6.5 Beckman Coulter

6.5.1 Beckman Coulter Company Information

6.5.2 Beckman Coulter Description and Business Overview

6.5.3 Beckman Coulter Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Beckman Coulter Sustained Release Drug Delivery Systems Product Portfolio

6.5.5 Beckman Coulter Recent Developments/Updates

6.6 Scios

6.6.1 Scios Company Information

6.6.2 Scios Description and Business Overview

6.6.3 Scios Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Scios Sustained Release Drug Delivery Systems Product Portfolio

6.6.5 Scios Recent Developments/Updates

6.7 Noven Pharmaceuticals

6.7.1 Noven Pharmaceuticals Company Information

6.7.2 Noven Pharmaceuticals Description and Business Overview

6.7.3 Noven Pharmaceuticals Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Noven Pharmaceuticals Sustained Release Drug Delivery Systems Product Portfolio

6.7.5 Noven Pharmaceuticals Recent Developments/Updates

6.8 Raritan Pharmaceuticals

6.8.1 Raritan Pharmaceuticals Company Information

6.8.2 Raritan Pharmaceuticals Description and Business Overview

6.8.3 Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Product Portfolio

6.8.5 Raritan Pharmaceuticals Recent Developments/Updates

6.9 Parker Hannifin

6.9.1 Parker Hannifin Company Information

6.9.2 Parker Hannifin Description and Business Overview

6.9.3 Parker Hannifin Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Parker Hannifin Sustained Release Drug Delivery Systems Product Portfolio

6.9.5 Parker Hannifin Recent Developments/Updates

6.10 Nitto Avecia Pharma Services

6.10.1 Nitto Avecia Pharma Services Company Information

6.10.2 Nitto Avecia Pharma Services Description and Business Overview

6.10.3 Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Product Portfolio

6.10.5 Nitto Avecia Pharma Services Recent Developments/Updates

6.11 KV Pharmaceutical

6.11.1 KV Pharmaceutical Company Information

6.11.2 KV Pharmaceutical Description and Business Overview

6.11.3 KV Pharmaceutical Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.11.4 KV Pharmaceutical Sustained Release Drug Delivery Systems Product Portfolio

6.11.5 KV Pharmaceutical Recent Developments/Updates

6.12 Equashield

6.12.1 Equashield Company Information

6.12.2 Equashield Description and Business Overview

6.12.3 Equashield Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Equashield Sustained Release Drug Delivery Systems Product Portfolio

6.12.5 Equashield Recent Developments/Updates

6.13 Shire Laboratories

6.13.1 Shire Laboratories Company Information

6.13.2 Shire Laboratories Description and Business Overview

6.13.3 Shire Laboratories Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Shire Laboratories Sustained Release Drug Delivery Systems Product Portfolio

6.13.5 Shire Laboratories Recent Developments/Updates

6.14 Powder Systems

6.14.1 Powder Systems Company Information

6.14.2 Powder Systems Description and Business Overview

6.14.3 Powder Systems Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Powder Systems Sustained Release Drug Delivery Systems Product Portfolio

6.14.5 Powder Systems Recent Developments/Updates

6.15 B. Braun OEM Division

6.15.1 B. Braun OEM Division Company Information

6.15.2 B. Braun OEM Division Description and Business Overview

6.15.3 B. Braun OEM Division Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.15.4 B. Braun OEM Division Sustained Release Drug Delivery Systems Product Portfolio

6.15.5 B. Braun OEM Division Recent Developments/Updates

6.16 Pharmaco-Kinesis

6.16.1 Pharmaco-Kinesis Company Information

6.16.2 Pharmaco-Kinesis Description and Business Overview

6.16.3 Pharmaco-Kinesis Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Pharmaco-Kinesis Sustained Release Drug Delivery Systems Product Portfolio

6.16.5 Pharmaco-Kinesis Recent Developments/Updates

6.17 Foresee

6.17.1 Foresee Company Information

6.17.2 Foresee Description and Business Overview

6.17.3 Foresee Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Foresee Sustained Release Drug Delivery Systems Product Portfolio

6.17.5 Foresee Recent Developments/Updates

6.18 Bayer

6.18.1 Bayer Company Information

6.18.2 Bayer Description and Business Overview

6.18.3 Bayer Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Bayer Sustained Release Drug Delivery Systems Product Portfolio

6.18.5 Bayer Recent Developments/Updates

6.19 Catalent

6.19.1 Catalent Company Information

6.19.2 Catalent Description and Business Overview

6.19.3 Catalent Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Catalent Sustained Release Drug Delivery Systems Product Portfolio

6.19.5 Catalent Recent Developments/Updates

6.20 Pfizer

6.20.1 Pfizer Company Information

6.20.2 Pfizer Description and Business Overview

6.20.3 Pfizer Sustained Release Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)

6.20.4 Pfizer Sustained Release Drug Delivery Systems Product Portfolio

6.20.5 Pfizer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Sustained Release Drug Delivery Systems Industry Chain Analysis

7.2 Sustained Release Drug Delivery Systems Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Sustained Release Drug Delivery Systems Production Mode & Process Analysis

7.4 Sustained Release Drug Delivery Systems Sales and Marketing

7.4.1 Sustained Release Drug Delivery Systems Sales Channels

7.4.2 Sustained Release Drug Delivery Systems Distributors

7.5 Sustained Release Drug Delivery Systems Customer Analysis

8 Sustained Release Drug Delivery Systems Market Dynamics

8.1 Sustained Release Drug Delivery Systems Industry Trends

8.2 Sustained Release Drug Delivery Systems Market Drivers

8.3 Sustained Release Drug Delivery Systems Market Challenges

8.4 Sustained Release Drug Delivery Systems Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

West Pharmaceutical Services

Noven Pharmaceuticals

Raritan Pharmaceuticals

Parker Hannifin

Nitto Avecia Pharma Services

List of Tables

Table 1. Global Sustained Release Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Sustained Release Drug Delivery Systems Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Sustained Release Drug Delivery Systems Market Competitive Situation by Manufacturers in 2024

Table 4. Global Sustained Release Drug Delivery Systems Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Sustained Release Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Sustained Release Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Sustained Release Drug Delivery Systems Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Sustained Release Drug Delivery Systems Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Sustained Release Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Sustained Release Drug Delivery Systems, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Sustained Release Drug Delivery Systems, Product Type & Application

Table 12. Global Key Manufacturers of Sustained Release Drug Delivery Systems, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Sustained Release Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Drug Delivery Systems as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Sustained Release Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Sustained Release Drug Delivery Systems Sales by Region (2020-2025) & (K Units)

Table 18. Global Sustained Release Drug Delivery Systems Sales Market Share by Region (2020-2025)

Table 19. Global Sustained Release Drug Delivery Systems Sales by Region (2026-2031) & (K Units)

Table 20. Global Sustained Release Drug Delivery Systems Sales Market Share by Region (2026-2031)

Table 21. Global Sustained Release Drug Delivery Systems Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Sustained Release Drug Delivery Systems Revenue Market Share by Region (2020-2025)

Table 23. Global Sustained Release Drug Delivery Systems Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Sustained Release Drug Delivery Systems Revenue Market Share by Region (2026-2031)

Table 25. North America Sustained Release Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Sustained Release Drug Delivery Systems Sales by Country (2020-2025) & (K Units)

Table 27. North America Sustained Release Drug Delivery Systems Sales by Country (2026-2031) & (K Units)

Table 28. North America Sustained Release Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Sustained Release Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Sustained Release Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Sustained Release Drug Delivery Systems Sales by Country (2020-2025) & (K Units)

Table 32. Europe Sustained Release Drug Delivery Systems Sales by Country (2026-2031) & (K Units)

Table 33. Europe Sustained Release Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Sustained Release Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Sustained Release Drug Delivery Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Sustained Release Drug Delivery Systems Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Sustained Release Drug Delivery Systems Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Sustained Release Drug Delivery Systems Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Sustained Release Drug Delivery Systems Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Sustained Release Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Sustained Release Drug Delivery Systems Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Sustained Release Drug Delivery Systems Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Sustained Release Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Sustained Release Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Sustained Release Drug Delivery Systems Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Sustained Release Drug Delivery Systems Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Sustained Release Drug Delivery Systems Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Sustained Release Drug Delivery Systems Sales (K Units) by Type (2020-2025)

Table 51. Global Sustained Release Drug Delivery Systems Sales (K Units) by Type (2026-2031)

Table 52. Global Sustained Release Drug Delivery Systems Sales Market Share by Type (2020-2025)

Table 53. Global Sustained Release Drug Delivery Systems Sales Market Share by Type (2026-2031)

Table 54. Global Sustained Release Drug Delivery Systems Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Sustained Release Drug Delivery Systems Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Sustained Release Drug Delivery Systems Revenue Market Share by Type (2020-2025)

Table 57. Global Sustained Release Drug Delivery Systems Revenue Market Share by Type (2026-2031)

Table 58. Global Sustained Release Drug Delivery Systems Price (USD/Unit) by Type (2020-2025)

Table 59. Global Sustained Release Drug Delivery Systems Price (USD/Unit) by Type (2026-2031)

Table 60. Global Sustained Release Drug Delivery Systems Sales (K Units) by Application (2020-2025)

Table 61. Global Sustained Release Drug Delivery Systems Sales (K Units) by Application (2026-2031)

Table 62. Global Sustained Release Drug Delivery Systems Sales Market Share by Application (2020-2025)

Table 63. Global Sustained Release Drug Delivery Systems Sales Market Share by Application (2026-2031)

Table 64. Global Sustained Release Drug Delivery Systems Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Sustained Release Drug Delivery Systems Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Sustained Release Drug Delivery Systems Revenue Market Share by Application (2020-2025)

Table 67. Global Sustained Release Drug Delivery Systems Revenue Market Share by Application (2026-2031)

Table 68. Global Sustained Release Drug Delivery Systems Price (USD/Unit) by Application (2020-2025)

Table 69. Global Sustained Release Drug Delivery Systems Price (USD/Unit) by Application (2026-2031)

Table 70. West Pharmaceutical Services Company Information

Table 71. West Pharmaceutical Services Description and Business Overview

Table 72. West Pharmaceutical Services Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. West Pharmaceutical Services Sustained Release Drug Delivery Systems Product

Table 74. West Pharmaceutical Services Recent Developments/Updates

Table 75. Cirtec Medical Company Information

Table 76. Cirtec Medical Description and Business Overview

Table 77. Cirtec Medical Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Cirtec Medical Sustained Release Drug Delivery Systems Product

Table 79. Cirtec Medical Recent Developments/Updates

Table 80. Balda Company Information

Table 81. Balda Description and Business Overview

Table 82. Balda Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Balda Sustained Release Drug Delivery Systems Product

Table 84. Balda Recent Developments/Updates

Table 85. Lubrizol Company Information

Table 86. Lubrizol Description and Business Overview

Table 87. Lubrizol Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Lubrizol Sustained Release Drug Delivery Systems Product

Table 89. Lubrizol Recent Developments/Updates

Table 90. Beckman Coulter Company Information

Table 91. Beckman Coulter Description and Business Overview

Table 92. Beckman Coulter Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Beckman Coulter Sustained Release Drug Delivery Systems Product

Table 94. Beckman Coulter Recent Developments/Updates

Table 95. Scios Company Information

Table 96. Scios Description and Business Overview

Table 97. Scios Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Scios Sustained Release Drug Delivery Systems Product

Table 99. Scios Recent Developments/Updates

Table 100. Noven Pharmaceuticals Company Information

Table 101. Noven Pharmaceuticals Description and Business Overview

Table 102. Noven Pharmaceuticals Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Noven Pharmaceuticals Sustained Release Drug Delivery Systems Product

Table 104. Noven Pharmaceuticals Recent Developments/Updates

Table 105. Raritan Pharmaceuticals Company Information

Table 106. Raritan Pharmaceuticals Description and Business Overview

Table 107. Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Raritan Pharmaceuticals Sustained Release Drug Delivery Systems Product

Table 109. Raritan Pharmaceuticals Recent Developments/Updates

Table 110. Parker Hannifin Company Information

Table 111. Parker Hannifin Description and Business Overview

Table 112. Parker Hannifin Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Parker Hannifin Sustained Release Drug Delivery Systems Product

Table 114. Parker Hannifin Recent Developments/Updates

Table 115. Nitto Avecia Pharma Services Company Information

Table 116. Nitto Avecia Pharma Services Description and Business Overview

Table 117. Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Nitto Avecia Pharma Services Sustained Release Drug Delivery Systems Product

Table 119. Nitto Avecia Pharma Services Recent Developments/Updates

Table 120. KV Pharmaceutical Company Information

Table 121. KV Pharmaceutical Description and Business Overview

Table 122. KV Pharmaceutical Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. KV Pharmaceutical Sustained Release Drug Delivery Systems Product

Table 124. KV Pharmaceutical Recent Developments/Updates

Table 125. Equashield Company Information

Table 126. Equashield Description and Business Overview

Table 127. Equashield Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Equashield Sustained Release Drug Delivery Systems Product

Table 129. Equashield Recent Developments/Updates

Table 130. Shire Laboratories Company Information

Table 131. Shire Laboratories Description and Business Overview

Table 132. Shire Laboratories Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Shire Laboratories Sustained Release Drug Delivery Systems Product

Table 134. Shire Laboratories Recent Developments/Updates

Table 135. Powder Systems Company Information

Table 136. Powder Systems Description and Business Overview

Table 137. Powder Systems Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Powder Systems Sustained Release Drug Delivery Systems Product

Table 139. Powder Systems Recent Developments/Updates

Table 140. B. Braun OEM Division Company Information

Table 141. B. Braun OEM Division Description and Business Overview

Table 142. B. Braun OEM Division Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. B. Braun OEM Division Sustained Release Drug Delivery Systems Product

Table 144. B. Braun OEM Division Recent Developments/Updates

Table 145. Pharmaco-Kinesis Company Information

Table 146. Pharmaco-Kinesis Description and Business Overview

Table 147. Pharmaco-Kinesis Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Pharmaco-Kinesis Sustained Release Drug Delivery Systems Product

Table 149. Pharmaco-Kinesis Recent Developments/Updates

Table 150. Foresee Company Information

Table 151. Foresee Description and Business Overview

Table 152. Foresee Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. Foresee Sustained Release Drug Delivery Systems Product

Table 154. Foresee Recent Developments/Updates

Table 155. Bayer Company Information

Table 156. Bayer Description and Business Overview

Table 157. Bayer Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 158. Bayer Sustained Release Drug Delivery Systems Product

Table 159. Bayer Recent Developments/Updates

Table 160. Catalent Company Information

Table 161. Catalent Description and Business Overview

Table 162. Catalent Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 163. Catalent Sustained Release Drug Delivery Systems Product

Table 164. Catalent Recent Developments/Updates

Table 165. Pfizer Company Information

Table 166. Pfizer Description and Business Overview

Table 167. Pfizer Sustained Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 168. Pfizer Sustained Release Drug Delivery Systems Product

Table 169. Pfizer Recent Developments/Updates

Table 170. Key Raw Materials Lists

Table 171. Raw Materials Key Suppliers Lists

Table 172. Sustained Release Drug Delivery Systems Distributors List

Table 173. Sustained Release Drug Delivery Systems Customers List

Table 174. Sustained Release Drug Delivery Systems Market Trends

Table 175. Sustained Release Drug Delivery Systems Market Drivers

Table 176. Sustained Release Drug Delivery Systems Market Challenges

Table 177. Sustained Release Drug Delivery Systems Market Restraints

Table 178. Research Programs/Design for This Report

Table 179. Key Data Information from Secondary Sources

Table 180. Key Data Information from Primary Sources

Table 181. Authors List of This Report

List of Figures

Figure 1. Product Picture of Sustained Release Drug Delivery Systems

Figure 2. Global Sustained Release Drug Delivery Systems Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sustained Release Drug Delivery Systems Market Share by Type: 2024 & 2031

Figure 4. Nonbiodegradable Implants Product Picture

Figure 5. Biodegradable Implants Product Picture

Figure 6. Micro- and Nano-Particles Product Picture

Figure 7. Liposomes Product Picture

Figure 8. ECT Product Picture

Figure 9. Global Sustained Release Drug Delivery Systems Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Sustained Release Drug Delivery Systems Market Share by Application: 2024 & 2031

Figure 11. Hospitals

Figure 12. Clinics

Figure 13. Others

Figure 14. Global Sustained Release Drug Delivery Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Sustained Release Drug Delivery Systems Market Size (2020-2031) & (US$ Million)

Figure 16. Global Sustained Release Drug Delivery Systems Sales (2020-2031) & (K Units)

Figure 17. Global Sustained Release Drug Delivery Systems Average Price (USD/Unit) & (2020-2031)

Figure 18. Sustained Release Drug Delivery Systems Report Years Considered

Figure 19. Sustained Release Drug Delivery Systems Sales Share by Manufacturers in 2024

Figure 20. Global Sustained Release Drug Delivery Systems Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Sustained Release Drug Delivery Systems Players: Market Share by Revenue in Sustained Release Drug Delivery Systems in 2024

Figure 22. Sustained Release Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Sustained Release Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Sustained Release Drug Delivery Systems Sales Market Share by Country (2020-2031)

Figure 25. North America Sustained Release Drug Delivery Systems Revenue Market Share by Country (2020-2031)

Figure 26. United States Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Sustained Release Drug Delivery Systems Sales Market Share by Country (2020-2031)

Figure 29. Europe Sustained Release Drug Delivery Systems Revenue Market Share by Country (2020-2031)

Figure 30. Germany Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Sustained Release Drug Delivery Systems Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Sustained Release Drug Delivery Systems Revenue Market Share by Region (2020-2031)

Figure 37. China Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. China Taiwan Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Sustained Release Drug Delivery Systems Sales Market Share by Country (2020-2031)

Figure 47. Latin America Sustained Release Drug Delivery Systems Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Sustained Release Drug Delivery Systems Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Sustained Release Drug Delivery Systems Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. UAE Sustained Release Drug Delivery Systems Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Sustained Release Drug Delivery Systems by Type (2020-2031)

Figure 57. Global Revenue Market Share of Sustained Release Drug Delivery Systems by Type (2020-2031)

Figure 58. Global Sustained Release Drug Delivery Systems Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Sustained Release Drug Delivery Systems by Application (2020-2031)

Figure 60. Global Revenue Market Share of Sustained Release Drug Delivery Systems by Application (2020-2031)

Figure 61. Global Sustained Release Drug Delivery Systems Price (USD/Unit) by Application (2020-2031)

Figure 62. Sustained Release Drug Delivery Systems Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sustained Release Coatings Market Insights Forecast to 2030

Global Sustained Release Injectables Market Research Report 2024

Smart Drug Delivery Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global TDS Transdermal Delivery Systems Market Insights Forecast to 2030

Global Sustained release Medicine Market Research Report 2025

Global Targeted Drug Delivery System Market Research Report 2025

Global Soft Implantable Drug Delivery System Market Research Report 2024

Sodium Valproate SR Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hydrogel Drug Delivery Systems DDS Market Research Report 2025

Global Nano based Drug Delivery System Market Research Report 2024

Global Nanotechnology based Drug Delivery Systems Market Research Report 2024

Global Adhesive Solutions for Drug Delivery Polymer Market Research Report 2024

Sustained Release Film Coating Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Intelligent Drug Release System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drug Delivery Device Market Research Report 2024

Global Smart Drug releasing Patches Market Research Report 2025

Global Sustained and Controlled Release Formulations Market Research Report 2025

Global Smart Drug Delivery System Market Research Report 2024

Global Transdermal Drug Delivery System Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions